SKI Market

Indian Indices

Nifty

22,055.20 97.70
(0.44%)

Sensex

72,664.47 260.30
( 0.36%)

Bank Nifty

47,421.10 -66.80
( -0.14%)

Nifty IT

32,935.15 -270.70
( -0.82%)

Global Indices

Nasdaq

16,340.87 -5.39
(-0.03%)

Dow Jones

39,512.84 125.08
(0.32%)

Hang Seng

18,963.68 425.87
(2.30%)

Nikkei 225

38,229.11 155.13
(0.41%)

Forex

USD-INR

83.52 0.04
(0.05%)

EUR-INR

89.99 0.20
(0.22%)

GBP-INR

104.60 0.26
(0.25%)

JPY-INR

0.54 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Balaxi Pharmaceuticals Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

532597

INE618N01014

117.0934413

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BALAXI

79.95

653.48

EPS(TTM)

Face Value()

Div & Yield %

7.5

Back

balaxi pharmaceuticals ltd

Balaxi Pharmaceuticals standalone net profit declines 70.35% in the September 2023 quarter

Nov 02,2023

Net profit of Balaxi Pharmaceuticals declined 70.35% to Rs 1.18 crore in the quarter ended September 2023 as against Rs 3.98 crore during the previous quarter ended September 2022. Sales declined 41.44% to Rs 16.55 crore in the quarter ended September 2023 as against Rs 28.26 crore during the previous quarter ended September 2022.

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	16.55	28.26	-41
OPM %	5.50	12.49	-
PBDT	1.70	6.01	-72
PBT	1.57	5.93	-74
NP	1.18	3.98	-70

22,055.20 97.70 (0.44%)

72,664.47 260.30 ( 0.36%)

47,421.10 -66.80 ( -0.14%)

32,935.15 -270.70 ( -0.82%)

16,340.87 -5.39 (-0.03%)

39,512.84 125.08 (0.32%)

18,963.68 425.87 (2.30%)

38,229.11 155.13 (0.41%)

83.52 0.04 (0.05%)

89.99 0.20 (0.22%)

104.60 0.26 (0.25%)

0.54 0.00 (-0.02%)